Custom Search
FDA Information
Levaquin® (levofloxacin) was approved by the Food and Drug Administration for 9 indications including the treatment of complicated skin and skin structure infections at a dose of 750 mg once daily.
The U.S. FDA has approved a new, once daily formulation of Levaquin® in a 25 mg/mL oral solution.
Why is this medication prescribed?
Dosage and using this medicine
What special precautions should I follow?
What should I do if I forget a dose?
What side effects can this medication cause?